EVALUATION OF THE STATUS OF PRENATAL SCREENING AND DIAGNOSIS OF DOWN SYNDROME AT NGHE AN OBSTETRICS AND PEDIATRICS HOSPITAL
Main Article Content
Abstract
Objectives: Evaluation of the status of prenatal screening and diagnosis of Down syndrome
Subjects and methods: Retrospective, cross-sectional descriptive study on 33 fetuses and 73
children diagnosed with Down syndrome at Center for prenatal and neonatal diagnostic and
screening – Nghe An Obstetrics and Pediatrics Hospital from 7/2020 to 7/2022
Results: Fetal ultrasound is a common prenatal screening method, providing the indication for
prenatal diagnosis (amniocentesis). There were 2/33 (6%) fetus of Down syndrome with normal
fetal ultrasound but positive Trisomy 21 NIPT. Amniocentesis implemented after 20 weeks had
6/33 (18,2%) cases. In 73 Down syndrome children: 15/73 (29.5%) cases with abnormalities on
fetal ultrasound were recorded when information was collected from the family; screening by
maternal blood (Double test/Triple test/NIPT) was performed in 11/73 cases, accounting for
15.1%.
Conclusion: Combining maternal serum screening/NIPT with periodic ultrasound (under the
guidance of the Ministry of Health) would help early prenatal diagnosis of DS. Raising awareness
about prenatal screening and diagnosis for families in Nghe An and surrounding areas is an
extremely vital issue.
Article Details
Keywords
Down syndrome, prenatal screening, prenatal diagnosis.
References
Down Syndrome: Current Status, Challenges
and Future Perspectives. Int J Mol Cell Med,
5(3), 125–133, 2016.
2. Antonarakis SE, Skotko BG, Rafii MS et
al., Down syndrome. Nat Rev Dis Primer, 6(1),
9, 2020.
3. American College of Obstetricians and
Gynecologists’ Committee on Practice
Bulletins—Obstetrics, Committee on Genetics,
và Society for Maternal-Fetal Medicine (2020).
Screening for Fetal Chromosomal
Abnormalities: ACOG Practice Bulletin,
Number 226. Obstet Gynecol, 136(4), e48–e69.
4. Gekas J, van den Berg DG, Durand A et
al., Rapid testing versus karyotyping in Down’s
syndrome screening: cost-effectiveness and
detection of clinically significant chromosome
abnormalities. Eur J Hum Genet, 19(1), 3–9,
2011.
5. Nguyễn Văn Rực, Nghiên cứu đặc điểm
karyotype, kiểu hình của trẻ Down và karyotype
của bố mẹ, Đại học Y Hà Nội, 2004.